Reuters Market Eye - The BSE Sensex gains 0.47 percent while Nifty up 0.38 percent, touching the highest intra-day level since January 24.
Gains supported by consistent foreign fund inflow as overseas investors have been net buyers of cash shares in each of the previous 10 sessions, with inflows totalling around $600 million, exchange and regulatory data show.
Pharmaceutical companies leading the gains with Dr Reddy's Laboratories up 2.02 percent, Cipla up 2.29 percent and Sun Pharmaceutical industries gaining 2.02 percent.
However, gains were limited after investors sold shares of Maruti Suzuki , which fell as much as 5.5 percent, as doubts persist about the impact of the automaker's plan to source cars from a plant to be built by its parent Suzuki Motor Co.
Shares in Jaiprakash Power Ventures and Jaiprakash Associated surge on market expectations that it could soon strike a $2-billion deal to sell two power plants to a group led by Abu Dhabi National Energy .
(Reporting by Indulal P)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
